ProQR Therapeutics NV Axiomer RNA Call Transcript
Good day, and thank you for standing by. Welcome to ProQR Therapeutics' The Axiomer Opportunity Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I'd now like to hand the conference over to the speaker today, Sarah Kiely. Please go ahead.
Thank you, operator, and good day, everyone. I am Sarah Kiely, Vice President of Investor Relations and Corporate Communications at ProQR. We are very pleased to share with you today an update on our Axiomer RNA editing platform technology, following the recent partnership announcement with Eli Lilly and Company.
Briefly, some logistics. This webcast can be accessed under the Events section of our website at www.proqr.com, and will be available for replay later today. The slides for the webcast can be downloaded from the webcast player or directly from our website.
I would also
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |